Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
131 participants
INTERVENTIONAL
2015-12-08
2021-11-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Intranasal Oxytocin on Fear Processing in Naturalistic Contexts
NCT05892939
Multiple Dose Effect of Oxytocin on Males With High or Low Trait Anxiety
NCT03085654
Threat Reversal Abnormality in Patients With Anxiety Disorders
NCT06232369
Threat-Avoidance Learning in Anxiety Patients
NCT02336802
Effects of Oxytocin on Behavior and Physiology in a Psychotherapy Setting
NCT01081249
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
high trait anxiety group
experiment 1: identified according to scores of the trait anxiety scale.
trait anxiety scale
splitting subjects into 2 groups according to scores of the trait anxiety scale
low trait anxiety group
experiment 1: identified according to scores of the trait anxiety scale.
trait anxiety scale
splitting subjects into 2 groups according to scores of the trait anxiety scale
oxytocin group
experiment 2: intranasal administration of oxytocin
Oxytocin
intranasal administration of oxytocin
placebo control group
experiment 2: intranasal administration of placebo
Placebo
intranasal administration of placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
trait anxiety scale
splitting subjects into 2 groups according to scores of the trait anxiety scale
Oxytocin
intranasal administration of oxytocin
Placebo
intranasal administration of placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Electronic Science and Technology of China
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Keith Kendrick
Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Keith Kendrick, Dr.
Role: PRINCIPAL_INVESTIGATOR
University of Electronic Science and Technology of China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
school of life science and technology, University of Electronic Science and Technology of China
Chengdu, Sichuan, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UESTC-neuSCAN_20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.